HealthEquity Inc (NASDAQ: HQY) has reported earnings for its fourth fiscal quarter (ending January 31) of $0.30 versus $0.31 for the same period a year ago — a decline of -3%. For the latest four […]
Euroseas Ltd (NASDAQ: ESEA) stock closed at $29.84 on 3/18/25 after a major decline of -11.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 216% of normal. The stock has been weak […]
Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $8.57 on 3/18/25 after a major decline of -30.2%. Moreover, trading volume in this decline was exceptionally high at 812% of normal. The stock has declined -17.0% […]
Harrow Health Inc (NASDAQ: HROW) stock closed at $26.98 on 3/18/25 after a major increase of 15.7%. Moreover, trading volume in this advance was exceptionally high at 521% of normal. The stock has risen 21.4% […]
On 3/18/25, Team Inc (NYSE: TISI) stock enjoyed a major increase of 17.2%, closing at $16.50. Moreover, exceptionally high trading volume at 323% of normal accompanied the advance. Relative to the market the stock has […]
On 3/18/25, Sarepta Therapeutics Inc (NASDAQ: SRPT) stock suffered a major decline of -27.4%, closing at $73.54. Moreover, this decline was accompanied by exceptionally high trading volume at 1107% of normal. Relative to the market […]
REGENXBIO Inc (NASDAQ: RGNX) stock closed at $7.80 on 3/18/25 after a major increase of 11.4%. Moreover, unusually high trading volume at 173% of normal accompanied the advance. The stock has risen 29.8% during the […]
On 3/18/25, Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) stock enjoyed a major increase of 26.1%, closing at $20.53. However, this advance was accompanied by exceptionally low trading volume at 0% of normal. Relative to the […]
Elbit Systems Ltd (NASDAQ: ESLT) has reported E.P.S. of $2.02 for its fourth fiscal quarter (ending December 31) versus $0.68 for the same period a year ago — an increase of 197%. For the latest […]
DallasNews Corporation (NASDAQ: DALN) stock closed at $5.70 on 3/18/25 after a major decline of -16.3%. Moreover, trading volume in this decline was exceptionally high at 361% of normal. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research